Human albumin (Grifols)

人白蛋白(Grifols)

Report date: 2023/01/13 20:00:32

Base Information

Drug NameHuman albumin (Grifols)
Drug Alias NameAlbuteinAlbumin
ClassificationBiologics > Blood components
Mechanisms of ActionAlbumins replacements
TargetsAlbumins
Therapy Area/IndicationsHypovolemiaLiver CirrhosisHepatic Encephalopathy
Global Approved IndicationsHypovolemia
Approved Indications in ChinaHypovolemia
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGrifols Therapeutics Llc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHypovolemiaLiver CirrhosisHepatic Encephalopathy
Inactive IndicationsN/A

Other Information

ATC CodeB05AA01
Related LinksN/A